Acetyldigitoxin
Acetyldigitoxin may decrease the cardiotoxic activities of Aflibercept.
Ancestim
The risk or severity of cytotoxicity can be increased when Ancestim is combined with Aflibercept.
Bevacizumab
Bevacizumab may increase the cardiotoxic activities of Aflibercept.
Advertisement
Bevacizumab-Awwb
Bevacizumab may increase the cardiotoxic activities of Aflibercept.
Cabazitaxel
The risk or severity of adverse effects can be increased when Cabazitaxel is combined with Aflibercept.
Cyclophosphamide
Cyclophosphamide may increase the cardiotoxic activities of Aflibercept.
Advertisement
Cyclophosphamide Anhydrous
Cyclophosphamide may increase the cardiotoxic activities of Aflibercept.
Deslanoside
Deslanoside may decrease the cardiotoxic activities of Aflibercept.
Digitoxin
Digitoxin may decrease the cardiotoxic activities of Aflibercept.
Advertisement
Digoxin
Digoxin may decrease the cardiotoxic activities of Aflibercept.
Docetaxel
The risk or severity of adverse effects can be increased when Docetaxel is combined with Aflibercept.
DOCETAXEL ANHYDROUS
The risk or severity of adverse effects can be increased when Docetaxel is combined with Aflibercept.
Ouabain
Ouabain may decrease the cardiotoxic activities of Aflibercept.
Ovine Digoxin Immune Fab
Digoxin Immune Fab (Ovine) may decrease the cardiotoxic activities of Aflibercept.
Paclitaxel
The risk or severity of adverse effects can be increased when Paclitaxel is combined with Aflibercept.
Proscillaridin
Proscillaridin may decrease the cardiotoxic activities of Aflibercept.
Trastuzumab
Trastuzumab may increase the cardiotoxic activities of Aflibercept.
